Sign inGet started

Gupta Ashoo

Insider CIK 2091461 · FDMT VP, Finance and Controller

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FDMT 4D Molecular Therapeutics, M Exercise deriv2026-03-202026-03-24221— $03,087SEC↗
FDMT 4D Molecular Therapeutics, M Exercise deriv2026-03-202026-03-24865— $012,119SEC↗
FDMT 4D Molecular Therapeutics, S Sale2026-03-202026-03-2480$8.61 $68947,055SEC↗
FDMT 4D Molecular Therapeutics, M Exercise2026-03-202026-03-24221— $047,135SEC↗
FDMT 4D Molecular Therapeutics, M Exercise2026-03-202026-03-24865— $047,224SEC↗
FDMT 4D Molecular Therapeutics, S Sale2026-03-202026-03-24310$8.61 $2.7K46,914SEC↗
FDMT 4D Molecular Therapeutics, M Exercise deriv2025-12-202025-12-23220— $03,308SEC↗
FDMT 4D Molecular Therapeutics, M Exercise deriv2025-12-202025-12-23866— $012,984SEC↗
FDMT 4D Molecular Therapeutics, M Exercise2025-12-202025-12-23866— $046,528SEC↗
FDMT 4D Molecular Therapeutics, S Sale2025-12-202025-12-2379$8.68 $68646,359SEC↗
FDMT 4D Molecular Therapeutics, M Exercise2025-12-202025-12-23220— $046,438SEC↗
FDMT 4D Molecular Therapeutics, S Sale2025-12-202025-12-23310$8.68 $2.7K46,218SEC↗